Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Levothyroxine Sodium Tablets 300 μg
Levothyroxine 300 μg · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Levothyroxine Sodium Tablets 300 μg |
| 2 | ACTIVE_COMPARATOR | Levothroid® Tablets 300 μg |
| Name | Type | Description |
|---|---|---|
| Levothyroxine Sodium Tablets 300 μg | DRUG | 2x300mcg, single dose fasting |
| Levothroid® Tablets 300 μg | DRUG | 2x300mcg, single dose fasting |
| Synthroid® Tablets 300 μg | DRUG | 2x300mcg, single dose fasting |
Inclusion Criteria: 1. Age: 18-50 years. 2. Sex: Men and/or non-pregnant, non-lactating women. 1. Women of childbearing potential must have negative serum β human chorionic gonadotropin (HCG) pregnancy tests performed within 14 days prior to of the study and on the evening prior to each dose ad...